CArdioMetabolism and Atherosclerotic PlaqUe progreSsion

Abroad (travel likely)Recruiting

Conditions

Coronary Artery Disease · Diabetes Mellitus, Type 2 · Dyslipidemias · Obesity · Metabolic Syndrome

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China

    Contact: Study coordinator (Jian Li, BS) · ruijincrc@126.com · 0086 021 64370045
    Contact: Principal Investigator (Ruiyan Zhang, M.D., Ph.D.)
    Lin Lu, M.D., Ph.D. (Sub-investigator)
    Fenghua Ding, M.D., Ph.D. (Sub-investigator)
    Xiaoqun Wang, M.D., Ph.D. (Sub-investigator)
    Ying Shen, M.D., Ph.D. (Sub-investigator)
    Lili Liu, M.E. (Sub-investigator)
    Shuo Feng, M.D. (Sub-investigator)
Study leads
  • Lin Lu, M.D., Ph.D.

    Study Director

    Ruijin Hospital, Shanghai Jiaotong School of Medicine

  • Fenghua Ding, M.D., Ph.D.

    Study Chair

    Ruijin Hospital, Shanghai Jiaotong School of Medicine

  • Ruiyan Zhang, M.D., Ph.D.

    Principal Investigator

    Ruijin Hospital, Shanghai Jiaotong School of Medicine